Dev

Cognitive resilience to Alzheimer neuropathologic changes in the Honolulu-Asia Aging Study and the Nun Study Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Vitamins D and K and Neuropathologically-Defined Alzheimer and Other Dementias in Older Persons Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Changes in arterial stiffness, cognition and dementia risk in a diverse cohort Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Nonlinear Models of Cognition Preceding AD and non-AD in a Biracial Population Sample Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Peripheral and brain levels of advanced glycation end products AGEs and incident Alzheimers disease and neuropathology Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Diabetes Status and Brain Amyloid in Middle Aged Hispanics Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA) Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The VETSA Longitudinal Twin Study of Cognition and Aging (VETSA 3) Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Sphingolipids and Inflammation in the Development and Progression of Alzheimers Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Modifier Genes that Influence Age at Onset or Protect Against Development of Alzheimers Disease (AD) Investments > €500k United States of America Alzheimer’s disease & other dementias 2016